Carla De Oliveira Bernardo1, David Alejandro González-Chica2, Monique Chilver3, Nigel Stocks4. 1. Discipline of General Practice, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia. Electronic address: carla.bernardo@adelaide.edu.au. 2. Discipline of General Practice, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia; Adelaide Rural Clinical School, The University of Adelaide, Adelaide, SA, Australia. 3. The Australian Sentinel Practices Research Network (ASPREN), The University of Adelaide, Adelaide, SA, Australia. 4. Discipline of General Practice, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia; Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE) Centre of Research Excellence, NHMRC, Australia.
Abstract
OBJECTIVES: To assess influenza immunisation rates and coverage in adult patients from Australian general practice and identify whether practice or patients' characteristics are associated with vaccination uptake. DESIGN: Open cohort study. SETTING: 550 Australian general practices included in the MedicineInsight database. PARTICIPANTS: Patients aged 18+ years who had at least one consultation during influenza season between 2015 and 2017. Two samples were considered: (1) 'active' patients (at least three consultations in any two consecutive years) and (2) 'every year' patients (at least one consultation per year). MAIN OUTCOME MEASURES: Influenza vaccination rates per 1,000 consultations and coverage (% vaccinated among those who consulted) from 2015 to 2017. RESULTS: Between 2015 and 2017 the influenza vaccine rate changed from 57.4 to 51.7 and 67.0 per 1,000 consultations, while correspondent values for coverage were 29.3%, 25.2% and 27.6% (in 'active' patients). Vaccine coverage was at least 30% higher in inner regional areas, among patients aged 65+ years or those with comorbidities. Similar associations were found among 'every year' patients, but average coverage across the three years was higher (41% vs 27%). Aboriginal and Torres Strait Islander people, either with or without comorbidity, showed a vaccine coverage 10-30% higher than non-Indigenous people for those aged less than 65 years (p-value for interaction < 0.001). CONCLUSION: MedicineInsight data is a useful and low-cost method to monitor influenza immunisation coverage. Independent of the sample used, vaccination coverage among Indigenous people or patients with comorbidities could be improved. Targeted strategies for high-risk groups need to be developed.
OBJECTIVES: To assess influenza immunisation rates and coverage in adult patients from Australian general practice and identify whether practice or patients' characteristics are associated with vaccination uptake. DESIGN: Open cohort study. SETTING: 550 Australian general practices included in the MedicineInsight database. PARTICIPANTS: Patients aged 18+ years who had at least one consultation during influenza season between 2015 and 2017. Two samples were considered: (1) 'active' patients (at least three consultations in any two consecutive years) and (2) 'every year' patients (at least one consultation per year). MAIN OUTCOME MEASURES: Influenza vaccination rates per 1,000 consultations and coverage (% vaccinated among those who consulted) from 2015 to 2017. RESULTS: Between 2015 and 2017 the influenza vaccine rate changed from 57.4 to 51.7 and 67.0 per 1,000 consultations, while correspondent values for coverage were 29.3%, 25.2% and 27.6% (in 'active' patients). Vaccine coverage was at least 30% higher in inner regional areas, among patients aged 65+ years or those with comorbidities. Similar associations were found among 'every year' patients, but average coverage across the three years was higher (41% vs 27%). Aboriginal and Torres Strait Islander people, either with or without comorbidity, showed a vaccine coverage 10-30% higher than non-Indigenous people for those aged less than 65 years (p-value for interaction < 0.001). CONCLUSION: MedicineInsight data is a useful and low-cost method to monitor influenza immunisation coverage. Independent of the sample used, vaccination coverage among Indigenous people or patients with comorbidities could be improved. Targeted strategies for high-risk groups need to be developed.